LYKA LABS LTD (LYKALABS) financials

LYKA LABS LTD (LYKALABS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages[1]

Market Cap: ₹317Cr.
Current Price: ₹87.8
ROE: -8.90%
ROCE: -4.65%
Book Value: ₹24.4
Dividend Yield: 0.00%
52W High / Low: ₹105/44.1

In Jun 2026, LYKA LABS LTD (LYKALABS) reported sales ₹42.31 Cr and net profit ₹2.10 Cr.

Annual TTM: sales ₹134 Cr, net profit ₹-31 Cr.

Shareholding: Promoters 58.45% (Sep 2026), FIIs 0.15% (Sep 2026), DIIs 0.66% (Sep 2026), Public 40.73% (Sep 2026), No. of Shareholders 25,885% (Sep 2026).

LYKALABS quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	41.16	32.92	30.52	29.18	32.97	30.73	28.03	42.31
Expenses	35.82	27.83	27.22	25.82	36.12	28.83	32.52	37.72
Operating Profit	5.34	5.09	3.30	3.36	-3.15	1.90	-4.49	4.59
OPM %	12.97%	15.46%	10.81%	11.51%	-9.55%	6.18%	-16.02%	10.85%
Other Income	0.13	0.87	0.82	0.77	1.21	1.37	-22.50	0.42
Interest	0.52	0.62	0.52	0.85	0.79	0.82	0.87	1.01
Depreciation	1.68	1.75	1.42	2.11	2.07	2.15	2.04	2.01
Profit before tax	3.27	3.59	2.18	1.17	-4.80	0.30	-29.90	1.99
Tax %	24.16%	24.79%	44.04%	30.77%	-24.38%	0.00%	-0.43%	-5.53%
Net Profit	2.47	2.70	1.23	0.81	-3.63	0.29	-29.77	2.10
EPS in Rs	0.69	0.76	0.34	0.23	-1.02	0.08	-8.34	0.58
Raw PDF	—	—	—	—	—	—	—	—

LYKALABS profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	41	62	164	81	106	135	121	134
Expenses	44	48	67	65	92	117	123	135
Operating Profit	-3	14	98	16	15	17	-2	-1
OPM %	-8%	23%	59%	19%	14%	13%	-2.0%	-0.9%
Other Income	-25	1	-2	-4	2	3	-19	-20
Interest	19	26	20	12	5	2	3	3
Depreciation	8	8	15	14	12	7	8	8
Profit before tax	-55	-18	60	-13	-1	11	-33	-32
Tax %	0%	-21%	34%	1%	143%	29%	-3%	—
Net Profit	-55	-14	40	-13	-2	8	-32	-31
EPS in Rs	-19.31	-5.04	13.91	-4.33	-0.69	2.22	-9.05	-8.70
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

LYKALABS balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	28	29	29	29	31	33	36	36
Reserves	70	-10	-24	16	46	66	86	51
Borrowings	91	137	163	129	74	59	39	49
Other Liabilities	59	66	46	35	28	28	32	35
Total Liabilities	249	221	213	209	179	186	193	171
Fixed Assets	76	102	95	90	66	56	85	87
CWIP	30	26	24	18	16	23	1	2
Investments	62	32	32	32	32	32	15	0
Other Assets	80	61	61	68	65	75	92	82
Total Assets	249	221	213	209	179	186	193	171

LYKALABS cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	18	-11	6	77	7	3	-2	5
Cash from Investing Activity	-3	0	0	-4	7	-9	-11	-9
Cash from Financing Activity	-16	20	-8	-63	-20	3	8	4
Net Cash Flow	-0	8	-2	9	-7	-3	-5	-0
Free Cash Flow	15	-12	4	71	13	-6	-14	-6
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	1,817%	381%	45%	79%	47%	31%	8%	-231%

LYKALABS shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	58.11%	58.16%	58.16%	58.16%	58.16%	58.16%	58.45%	58.45%
FIIs	0.15%	0.24%	0.16%	0.17%	0.17%	0.29%	0.17%	0.15%
DIIs	0.66%	0.66%	0.66%	0.66%	0.66%	0.66%	0.66%	0.66%
Public	41.07%	40.93%	41.02%	40.99%	40.99%	40.89%	40.73%	40.73%
No. of Shareholders	29,099	28,472	28,189	27,743	27,155	26,727	29,369	25,885

LYKALABS key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	263	59	58	39	78	88	110	99
Inventory Days	98	99	67	97	87	81	86	109
Days Payable	519	430	301	109	103	93	95	135
Cash Conversion Cycle	-159	-272	-176	26	62	77	100	74
Working Capital Days	-172	-296	-154	-137	16	28	64	17
ROCE %	-0%	-5%	5%	50%	3%	3%	8%	-5%

LYKALABSUpdated 18 Oct 2026, 20:08

Lyka Labs Ltd

LYKALABSUpdated 18 Oct 2026, 20:08

Market Cap

₹317Cr.

Current Price

₹87.8

High / Low

₹105/44.1

ROE-8.90%

ROCE-4.65%

Book Value₹24.4

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	21.24	1.33	18.69	0.43	3.34	-1.69	2.37	-1.72	-0.52
Sep 2023	26.76	1.17	22.82	0.25	3.46	-0.44	-34.09	-0.29	-0.09
Dec 2023	31.42	1.26	25.56	0.52	2.72	2.4	43.33	1.36	0.41
Mar 2024	26.98	1.04	24.76	0.38	2.77	-1.21	33.06	-1.62	-0.49
Jun 2024	30.1	0.65	26.05	0.62	1.68	2.34	25.64	1.75	0.49
Sep 2024	41.16	0.52	35.82	0.13	1.68	3.27	24.16	2.47	0.69
Dec 2024	32.92	0.62	27.83	0.87	1.75	3.59	24.79	2.7	0.76
Mar 2025	30.52	0.52	27.22	0.82	1.42	2.18	44.04	1.23	0.34
Jun 2025	29.18	0.85	25.82	0.77	2.11	1.17	30.77	0.81	0.23
Sep 2025	32.97	0.79	36.12	1.21	2.07	-4.8	-24.38	-3.63	-1.02
Dec 2025	30.73	0.82	28.83	1.37	2.15	0.3	0	0.29	0.08
Mar 2026	28.03	0.87	32.52	-22.5	2.04	-29.9	-0.43	-29.77	-8.34
Jun 2026	42.31	1.01	37.72	0.42	2.01	1.99	-5.53	2.1	0.58

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2015	90	18	72	5	4	1	0	1	0.63
Mar 2016 9m	57	11	49	11	3	5	0	5	2.19
Mar 2017	78	17	56	0	6	-1	-66	0	-0.09
Mar 2018	42	8	42	3	6	-11	-3	-11	-3.85
Mar 2019	41	6	40	2	4	-7	-124	2	0.61
Mar 2020	41	19	44	-25	8	-55	0	-55	-19.31
Mar 2021	62	26	48	1	8	-18	-21	-14	-5.04
Mar 2022	164	20	67	-2	15	60	34	40	13.91
Mar 2023	81	12	65	-4	14	-13	1	-13	-4.33
Mar 2024	106	5	92	2	12	-1	143	-2	-0.69
Mar 2025	135	2	117	3	7	11	29	8	2.22
Mar 2026	121	3	123	-19	8	-33	-3	-32	-9.05
TTM	134	3	135	-20	8	-32	—	-31	-8.7

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	58.45%
FIIs	0.15%
DIIs	0.66%
Public	40.73%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	54.81%	0.17%	0.62%	44.41%
Mar 2024	54.81%	0.17%	0.81%	44.21%
Jun 2024	58.11%	0.15%	0.75%	40.99%
Sep 2024	58.11%	0.15%	0.66%	41.08%
Dec 2024	58.11%	0.15%	0.66%	41.07%
Mar 2025	58.16%	0.24%	0.66%	40.93%
Jun 2025	58.16%	0.16%	0.66%	41.02%
Sep 2025	58.16%	0.17%	0.66%	40.99%
Dec 2025	58.16%	0.17%	0.66%	40.99%
Mar 2026	58.16%	0.29%	0.66%	40.89%
Jun 2026	58.45%	0.17%	0.66%	40.73%
Sep 2026	58.45%	0.15%	0.66%	40.73%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Jun 2015	22	38	109	64	233	62	27	63	82	233
Mar 2016	22	43	106	57	228	60	30	63	75	228
Mar 2017	22	52	112	57	243	86	24	62	70	243
Mar 2018	28	69	102	46	245	81	26	62	75	245
Mar 2019	28	70	91	59	249	76	30	62	80	249
Mar 2020	29	-10	137	66	221	102	26	32	61	221
Mar 2021	29	-24	163	46	213	95	24	32	61	213
Mar 2022	29	16	129	35	209	90	18	32	68	209
Mar 2023	31	46	74	28	179	66	16	32	65	179
Mar 2024	33	66	59	28	186	56	23	32	75	186
Mar 2025	36	86	39	32	193	85	1	15	92	193
Mar 2026	36	51	49	35	171	87	2	0	82	171

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Jun 2015	29	30	-63	-3
Mar 2016	8	5	-13	0
Mar 2017	20	-5	-15	0
Mar 2018	7	-3	-4	-1
Mar 2019	18	-3	-16	0
Mar 2020	-11	0	20	8
Mar 2021	6	0	-8	-2
Mar 2022	77	-4	-63	9
Mar 2023	7	7	-20	-7
Mar 2024	3	-9	3	-3
Mar 2025	-2	-11	8	-5
Mar 2026	5	-9	4	0

Key ratios

Historical financial ratios

Category	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	116	169	113	265	263	59	58	39	78	88	110	99
Inventory Days	90	74	93	124	98	99	67	97	87	81	86	109
Days Payable	283	323	283	536	519	430	301	109	103	93	95	135
Cash Conversion Cycle	-77	-80	-76	-147	-159	-272	-176	26	62	77	100	74
Working Capital Days	-313	-491	-398	-768	-172	-296	-154	-137	16	28	64	17
ROCE %	9%	9%	10%	-3%	-0%	-5%	5%	50%	3%	3%	8%	-5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of LYKA LABS LTD (LYKALABS)?

The reported market capitalisation for LYKA LABS LTD (LYKALABS) is ₹317Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of LYKALABS?

The current price shown for LYKA LABS LTD (LYKALABS) on Fincrux is ₹87.8 with a 52-week high/low of ₹105/44.1.

What were LYKALABS latest quarterly results?

For Jun 2026, LYKA LABS LTD (LYKALABS) reported sales ₹42.31 Cr and net profit ₹2.10 Cr (figures in ₹ crore unless noted).

What are LYKALABS annual sales and net profit?

For TTM, LYKA LABS LTD (LYKALABS) shows sales of ₹134 Cr and net profit of ₹-31 Cr on the Fincrux profit & loss statement.

Who owns LYKA LABS LTD (LYKALABS)?

Latest shareholding for LYKA LABS LTD (LYKALABS) on Fincrux: Promoters 58.45% (Sep 2026), FIIs 0.15% (Sep 2026), DIIs 0.66% (Sep 2026), Public 40.73% (Sep 2026), No. of Shareholders 25,885% (Sep 2026).

Where can I find LYKA LABS LTD (LYKALABS) financials?

LYKA LABS LTD (LYKALABS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show LYKALABS balance sheet and cash flow?

Yes. The LYKA LABS LTD (LYKALABS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 20:08